The roles of innate and adaptive immunity in inactivated viral vaccination-mediated protection against COVID-19

Shanhe Yu; Shijun Chen; Jiang Zhu; Jieming Qu

doi:10.1002/ctm2.1530

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (1) : e1530 DOI: 10.1002/ctm2.1530

COMMENTARY

The roles of innate and adaptive immunity in inactivated viral vaccination-mediated protection against COVID-19

Shanhe Yu ¹
, Shijun Chen ¹
, Jiang Zhu ¹^,^†
, Jieming Qu ²^,³^,^†

Author information +

History +

PDF

Keywords

COVID-19 / inactivated viral vaccination / innate and adaptive immunity / trained immunity

Cite this article

Download citation ▾

Shanhe Yu, Shijun Chen, Jiang Zhu, Jieming Qu. The roles of innate and adaptive immunity in inactivated viral vaccination-mediated protection against COVID-19. Clinical and Translational Medicine, 2024, 14(1): e1530 DOI:10.1002/ctm2.1530

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Cao Y, Jian F, Wang J, et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature. 2023;614(7948):521-529.

[2]	McMenamin ME, Nealon J, Lin Y, et al. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study. Lancet Infect Dis. 2022;22(10):1435-1443.

[3]	Tsang NNY, So HC, Cowling BJ, Leung GM, Ip DKM. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study. Lancet Infect Dis. 2023;23(4):421-434.

[4]	Yu S, Lin Y, Li Y, et al. Systemic immune profiling of Omicron-infected subjects inoculated with different doses of inactivated virus vaccine. Cell. 2023;186(21):4615-4631.e16.

[5]	Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27(7):1205-1211.

[6]	Lim JME, Hang SK, Hariharaputran S, et al. A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines. Cell Rep Med. 2022;3(11):100793.

[7]	Arunachalam PS, Scott MKD, Hagan T, et al. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature. 2021;596(7872):410-416.

[8]	Saresella M, Piancone F, Marventano I, et al. Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine. Front Immunol. 2022;13:947320.

[9]	Netea MG, Ziogas A, Benn CS, et al. The role of trained immunity in COVID-19: lessons for the next pandemic. Cell Host Microbe. 2023;31(6):890-901.

[10]	O'Neill LAJ, Netea MG. BCG-induced trained immunity: can it offer protection against COVID-19? Nat Rev Immunol. 2020;20(6):335-337.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.